4747 強生製藥歷年利潤比率
| 年度/季別 | 毛利率 | 營業利益率 | 稅前淨利率 | 稅後淨利率 |
|---|
| 2025Q2 | 39.86% | 14.76% | 17.20% | 13.96% |
| 2025Q1 | 40.21% | 16.85% | 18.45% | 14.71% |
| 2024Q4 | 41.07% | 14.39% | 16.92% | 13.47% |
| 2024Q3 | 40.93% | 18.57% | 20.12% | 14.13% |
| 2024Q2 | 41.45% | 16.49% | 18.49% | 15.06% |
| 2024Q1 | 38.93% | 14.88% | 15.75% | 12.48% |
| 2023Q4 | 38.57% | 12.77% | 14.40% | 11.39% |
| 2023Q3 | 39.99% | 16.00% | 14.90% | 11.61% |
| 2023Q2 | 41.69% | 17.52% | 18.35% | 14.51% |
| 2023Q1 | 41.04% | 18.96% | 18.88% | 15.04% |
| 2022Q4 | 42.00% | 16.53% | 16.61% | 13.14% |
| 2022Q3 | 43.85% | 18.96% | 19.04% | 15.20% |
| 2022Q2 | 38.63% | 15.51% | 15.40% | 12.31% |
| 2022Q1 | 40.38% | 14.83% | 14.53% | 11.51% |
| 2021Q4 | 40.79% | 15.14% | 14.75% | 11.74% |
| 2021Q3 | 43.08% | 16.77% | 16.68% | 13.23% |
| 2021Q2 | 43.21% | 16.39% | 16.41% | 13.02% |
| 2021Q1 | 40.21% | 12.41% | 12.54% | 9.88% |
| 2020Q4 | 45.60% | 16.52% | 16.30% | 12.85% |
| 2020Q3 | 45.47% | 16.98% | 16.98% | 13.49% |
| 2020Q2 | 47.29% | 18.81% | 19.25% | 18.19% |